4//SEC Filing
Febbo Phillip G. 4
Accession 0001649245-25-000005
CIK 0001384101other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:27 PM ET
Size
5.2 KB
Accession
0001649245-25-000005
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
- Sale
Common Stock
2025-10-06$36.02/sh−8,349$300,709→ 92,441 total
Footnotes (2)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $35.82 to $36.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Documents
Issuer
VERACYTE, INC.
CIK 0001384101
Entity typeother
Related Parties
1- filerCIK 0001649245
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:27 PM ET
- Size
- 5.2 KB